Skip to content

    Roivant Sciences (ROIV) stock price & financials

    View ROIV earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+189.5% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $4.47M
    $9.02M
    $7.57M
    $2.17M
    $1.57M
    -64.9%
    $2.00M
    -77.8%
    $2.52M
    -66.7%
    $1.44M
    -33.5%
    Weakening
    Operating Profit
    -$341.71M
    -$274.38M
    -$284.96M
    -$284.92M
    -$306.23M
    +10.4%
    -$339.15M
    -23.6%
    $415.24M
    -$365.99M
    -28.5%
    Weakening
    Net Profit
    -$230.18M
    $169.38M
    -$206.47M
    -$223.35M
    -$113.52M
    +50.7%
    -$265.89M
    -257.0%
    $302.99M
    -$189.84M
    +15.0%
    Weakening
    EPS
    $-0.31
    $0.23
    $-0.33
    $-0.17
    +45.2%
    $-0.38
    -265.2%
    $-0.26
    +21.2%
    Weakening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    -$224.38M
    -$234.51M
    -$203.05M
    -$269.26M
    -$159.04M
    +29.1%
    -$290.37M
    -23.8%
    $454.10M
    -$294.56M
    -9.4%
    Weakening
    MarginsOPM
    -7636.0%
    -3042.6%
    -3764.4%
    -13130.0%
    -19492.9%
    -155.3%
    -16966.1%
    -457.6%
    16477.8%
    -25380.9%
    -93.3%
    Weakening
    Tax
    -5.5%
    10.9%
    -24.3%
    -1.7%
    -4.4%
    +20.7%
    -8.0%
    -173.8%
    21.7%
    1.3%
    Weakening
    ReturnsROIC
    6.6%
    -4.8%
    5.9%
    6.4%
    3.2%
    -50.7%
    7.6%
    -8.7%
    -246.7%
    5.4%
    -15.0%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY21FY22FY23FY24FY25FY26TTM
    AssetsCash & Equivalents$2.06B$2.06B$1.68B$6.49B$2.72B$1.42B$1.25B
    Short-Term Investments$0$2.17B$2.87B$2.59B
    Total Current Assets$2.19B$2.15B$1.80B$6.73B$5.00B$5.17B$4.74B
    Net PP&E$77.03M$86.95M$92.34M$59.32M$101.08M$92.40M$90.21M
    Goodwill
    Intangibles$0$144.88M$137.84M
    Total Assets$2.59B$2.59B$2.39B$7.22B$5.44B$5.71B$5.31B
    LiabilitiesTotal Current Liabilities$218.96M$184.37M$272.45M$266.76M$149.41M$281.24M$283.60M
    Short-Term Debt$0$0$40.72M$12.00M
    Long-Term Debt$170.28M$210.03M$375.51M$430.59M
    Long-Term Leases$62.38M$62.47M$53.48M$45.02M$90.33M$96.29M$94.77M
    Total Liabilities$527.69M$523.70M$782.02M$773.95M$249.74M$416.27M$384.62M
    EquityCommon Stock & APIC$0$0$0$0$0$0$0
    Retained Earnings-$1.92B-$2.76B-$3.77B$576.17M$116.06M-$501.81M-$900.35M
    Total Equity$1.80B$1.66B$1.16B$5.97B$4.69B$4.53B$4.23B
    HighlightsNet Cash / (Debt)$1.88B$1.85B$1.26B$6.05B

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY21FY22FY23FY24FY25FY26TTM
    ActivitiesCash from Operating-$552.14M-$677.73M-$843.39M-$765.27M-$839.45M-$750.35M-$816.47M
    Cash from Investing-$31.70M$303.30M-$44.27M$5.20B-$1.77B-$682.33M$684.64M
    Cash from Financing$456.26M$306.79M$499.46M$419.36M-$1.22B$134.24M$140.49M
    SummaryCapital Expenditure-$5.81M-$17.44M-$12.69M-$1.38M-$4.60M-$8.21M-$4.59M
    Free Cash Flow-$557.94M-$695.16M-$856.08M-$766.65M-$844.05M-$758.56M-$821.06M
    FCF Margin-2344.8%-1257.4%-2715.1%-2343.6%-2905.2%-9183.5%-10901.0%

    Ratios